BRANDI N KINCAID
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family OSAGE BEACH, MO NPI 1144527490
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family MO ABBVIE INC. All categories
General Payments — all program years on this page
$2,441.01
- Category: General Payments
- Program years: PY2021–2024
- Record count: 136
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,163.26 across 67 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,163.26 | 67 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $219.16 | 11 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $195.43 | 11 |
| Celgene Corporation | $137.20 | 12 |
| Merck Sharp & Dohme Corporation | $86.87 | 4 |
| GlaxoSmithKline, LLC. | $64.32 | 4 |
| Genentech USA, Inc. | $60.34 | 3 |
| GENZYME CORPORATION | $44.14 | 3 |
| Karyopharm Therapeutics Inc. | $39.48 | 2 |
| JAZZ PHARMACEUTICALS INC. | $36.65 | 2 |
| Lilly USA, LLC | $35.56 | 2 |
| Incyte Corporation | $30.21 | 2 |
| Daiichi Sankyo Inc. | $29.01 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.56 | 1 |
| PFIZER INC. | $27.40 | 2 |
| Gilead Sciences, Inc. | $22.58 | 1 |
| Janssen Biotech, Inc. | $20.14 | 1 |
| Regeneron Healthcare Solutions, Inc. | $18.89 | 1 |
| EMD Serono, Inc. | $18.55 | 1 |
| Stemline Therapeutics Inc. | $17.34 | 1 |
| Blueprint Medicines Corporation | $17.34 | 1 |
| Dendreon Pharmaceuticals LLC | $15.09 | 1 |
By program year
Records — PY2024 (67)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.